O Cerná

634 total citations
20 papers, 192 citations indexed

About

O Cerná is a scholar working on Hematology, Genetics and Nutrition and Dietetics. According to data from OpenAlex, O Cerná has authored 20 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Genetics and 4 papers in Nutrition and Dietetics. Recurrent topics in O Cerná's work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (5 papers) and Vitamin C and Antioxidants Research (4 papers). O Cerná is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (5 papers) and Vitamin C and Antioxidants Research (4 papers). O Cerná collaborates with scholars based in Czechia, Slovakia and Netherlands. O Cerná's co-authors include E Ginter, F Hrubá, Véronique Roch, Pavla Pokorná, Ondřej Slanař, L Ozdín, F Perlı́k, Richard Kobza, Michael Doubek and Yvona Brychtová and has published in prestigious journals such as Blood, PLoS ONE and Food Chemistry.

In The Last Decade

O Cerná

19 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Cerná Czechia 9 61 48 46 40 30 20 192
Michael Hall Belgium 9 20 0.3× 22 0.5× 25 0.5× 67 1.7× 7 0.2× 16 257
Sohail Mushtaq United Kingdom 10 96 1.6× 14 0.3× 47 1.0× 62 1.6× 16 0.5× 22 292
Alicia Batchelor United States 7 78 1.3× 15 0.3× 28 0.6× 31 0.8× 18 0.6× 10 324
Ana Laura Pimentel Brazil 8 18 0.3× 38 0.8× 35 0.8× 58 1.4× 12 0.4× 12 336
S.E.A. Abdel Rahim United Kingdom 7 250 4.1× 12 0.3× 90 2.0× 23 0.6× 14 0.5× 13 385
Marwan M. Merkhan Iraq 11 24 0.4× 26 0.5× 6 0.1× 64 1.6× 29 1.0× 38 278
C.W. Flowers United States 7 186 3.0× 173 3.6× 339 7.4× 35 0.9× 12 0.4× 8 455
L. Zezza Italy 8 31 0.5× 6 0.1× 15 0.3× 43 1.1× 7 0.2× 18 281
Alessia Giorgini Italy 7 37 0.6× 5 0.1× 22 0.5× 21 0.5× 12 0.4× 12 232

Countries citing papers authored by O Cerná

Since Specialization
Citations

This map shows the geographic impact of O Cerná's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Cerná with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Cerná more than expected).

Fields of papers citing papers by O Cerná

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Cerná. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Cerná. The network helps show where O Cerná may publish in the future.

Co-authorship network of co-authors of O Cerná

This figure shows the co-authorship network connecting the top 25 collaborators of O Cerná. A scholar is included among the top collaborators of O Cerná based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Cerná. O Cerná is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Žáčková, Daniela, Hana Klamová, Edgar Faber, et al.. (2024). Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data. Cancer Medicine. 13(17). e70158–e70158.
2.
Mihaylov, Georgi, et al.. (2020). PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia. memo - Magazine of European Medical Oncology. 13(2). 227–234. 3 indexed citations
3.
Pokorná, Pavla, Martin Šíma, O Cerná, et al.. (2019). Actual body weight-based vancomycin dosing in neonates. Journal of Chemotherapy. 31(6). 307–312. 5 indexed citations
4.
Pokorná, Pavla, Martin Šíma, O Cerná, & Ondřej Slanař. (2019). Nomogram based on actual body weight for estimation of vancomycin maintenance dose in infants. Infectious Diseases. 51(5). 334–339. 5 indexed citations
6.
Jonášová, Anna, Jaroslav Čermák, Monika Beličková, et al.. (2015). [Lenalidomide treatment in myelodysplastic syndrome with 5q deletion--Czech MDS group experience].. PubMed. 61(12). 1028–33. 1 indexed citations
8.
Cerná, O, et al.. (2012). Effects of high tidal volume mechanical ventilation on production of cytokines, iNOS, and MIP-1β proteins in pigs. Experimental Lung Research. 39(1). 1–8. 7 indexed citations
9.
Cerná, O, Martin Šimkovič, Zdeněk Pospı́šil, et al.. (2012). Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice. International Journal of Hematology. 96(5). 594–599. 8 indexed citations
10.
Penka, Miroslav, Dagmar Pospı́šilová, Leoš Křen, et al.. (2012). [Summary of recommendations for the diagnosis and therapy of BCR/ABL-negative myeloproliferation of the Czech Working Group for Ph-negative myeloproliferative disease (CZEMP) of the Czech Hematologic Society CLS JEP ].. PubMed. 58(2). 163–8. 2 indexed citations
11.
Schwarz, Jiřı́, Miroslav Penka, Petra Ovesná, et al.. (2011). Thrombosis in MPN with Thrombocythemia Is Associated with Higher Platelet Count At the Time of the Event: Data From the Czech Registry of Patients Treated with Anagrelide,. Blood. 118(21). 3857–3857. 1 indexed citations
12.
Penka, Miroslav, Vít Campr, Dagmar Pospı́šilová, et al.. (2011). [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].. PubMed. 57(2). 189–213. 6 indexed citations
14.
Zemanová, Zuzana, K Michalová, Jana Březinová, et al.. (2008). Molecular Cytogenetic Studies of Complex Karyotypes in Myelodysplastic Syndromes (MDS): Conventional Cytogenetics, FISH and Multiplex FISH (mFISH/mBAND). Blood. 112(11). 5075–5075. 1 indexed citations
15.
Cerná, O, et al.. (1998). [Relation between levels of vitamins C, E, A and beta-carotene and activity of antioxidant enzymes in the blood].. PubMed. 99(5). 250–4. 9 indexed citations
16.
Cerná, O, et al.. (1992). Plasma lipids, lipoproteins and atherogenic index in men and women administered vitamin C.. PubMed. 34(3). 246–54. 8 indexed citations
17.
Kouba, K, et al.. (1987). [Congenital fatal toxoplasmosis sepsis].. PubMed. 52(6). 454–8. 1 indexed citations
18.
Ginter, E, et al.. (1978). Hypocholesterolemic effect of ascorbic acid in maturity-onset diabetes mellitus.. PubMed. 48(4). 368–73. 32 indexed citations
19.
Ginter, E, et al.. (1977). Effect of ascorbic acid on plasma cholesterol in humans in a long-term experiment.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 47(2). 123–34. 36 indexed citations
20.
Ginter, E, et al.. (1976). Vitamin C and plasma triglycerides in experimental animals and in humans. Food Chemistry. 1(1). 23–31. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026